Literature DB >> 9421353

Detailed deletion mapping at chromosome 9p21 in non-small cell lung cancer by microsatellite analysis and fluorescence in situ hybridization.

K Okami1, P Cairns, W H Westra, J F Linn, S A Ahrendt, L Wu, D Sidransky, J Jen.   

Abstract

We examined 82 cases of primary non-small cell lung cancer (NSCLC) for loss of heterozygosity (LOH) at the chromosome 9p21-24 region using 16 microsatellite markers. A total of 52 tumors (63%) displayed LOH, and 25 of these cases displayed LOH for all markers. Two cases had small hemizygous losses confined to the p16 gene and more distal markers, whereas 3 cases had loss proximal to p16 and extended through marker D9S126. This latter region has recently been described as another minimal region of loss at 9p21 in lung cancer. However, homozygous deletion of the p16 gene was observed in 18 of 85 cases, with only 5 cases having large deletions extended into the D9S126 region. Furthermore, we did not observe homozygous deletion at the 9p21 region that excluded the p16 gene. Fluorescence in situ hybridization (FISH) analysis using genomic probes spanning either the p16 or Hel-N1 (located at D9S126) gene was performed in 14 tumors. The results from FISH correlated with the chromosomal mapping data, suggesting that the p16 region is the major target of deletion at chromosome 9p21 in primary NSCLC.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421353     DOI: 10.1002/(sici)1097-0215(19971219)74:6<588::aid-ijc5>3.0.co;2-q

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  AIS is an oncogene amplified in squamous cell carcinoma.

Authors:  K Hibi; B Trink; M Patturajan; W H Westra; O L Caballero; D E Hill; E A Ratovitski; J Jen; D Sidransky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Amplification of chromosome 8 genes in lung cancer.

Authors:  Onur Baykara; Burak Bakir; Nur Buyru; Kamil Kaynak; Nejat Dalay
Journal:  J Cancer       Date:  2015-01-20       Impact factor: 4.207

3.  Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery.

Authors:  I El-Mokadem; J Fitzpatrick; J Bondad; P Rauchhaus; J Cunningham; N Pratt; S Fleming; G Nabi
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

4.  Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers.

Authors:  Naoki Yanagawa; Gen Tamura; Hiroyuki Oizumi; Nobumasa Takahashi; Yasuhisa Shimazaki; Teiichi Motoyama
Journal:  Jpn J Cancer Res       Date:  2002-10

Review 5.  Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy.

Authors:  Marion Grard; Camille Chatelain; Tiphaine Delaunay; Elvire Pons-Tostivint; Jaafar Bennouna; Jean-François Fonteneau
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

6.  Common genetic variants in the 9p21 region and their associations with multiple tumours.

Authors:  F Gu; R M Pfeiffer; S Bhattacharjee; S S Han; P R Taylor; S Berndt; H Yang; A J Sigurdson; J Toro; L Mirabello; M H Greene; N D Freedman; C C Abnet; S M Dawsey; N Hu; Y-L Qiao; T Ding; A V Brenner; M Garcia-Closas; R Hayes; L A Brinton; J Lissowska; N Wentzensen; C Kratz; L E Moore; R G Ziegler; W-H Chow; S A Savage; L Burdette; M Yeager; S J Chanock; N Chatterjee; M A Tucker; A M Goldstein; X R Yang
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

7.  Microsatellite alteration and immunohistochemical expression profile of chromosome 9p21 in patients with sporadic renal cell carcinoma following surgical resection.

Authors:  Ismail El-Mokadem; Alison Lim; Thomas Kidd; Katherine Garret; Norman Pratt; David Batty; Stewart Fleming; Ghulam Nabi
Journal:  BMC Cancer       Date:  2016-07-27       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.